Kyowa Kirin is an R&D-based life sciences company with special strengths in biotechnology. The Kyowa Kirin Group companies strive to contribute to the health and well-being of people around the world by creating new value through the pursuit of advances in life sciences and technologies.
You can see this table by scrolling horizontally.
|Company name||Kyowa Kirin Co., Ltd.|
|Establishment||July 1, 1949
|Capital||¥26,745 million (As of December 31, 2020)|
|Number of employees||5,423(Consolidated base, as of December 31, 2020)
|Representative Director of the Board||President & Chief Executive Officer : Masashi Miyamoto|
|Headquarters||Otemachi Financial City Grand Cube, 1-9-2 Otemachi,
Chiyoda-ku, Tokyo 100-0004
|Main Business||Research, development, manufacturing, marketing and import / export of pharmaceuticals|
|Parent Company||Kirin Holdings Company, Limited|
|History||History of Kyowa Kirin|